{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:32:37Z","timestamp":1791397957434,"version":"4.3.3"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.neuropharm.2022.109189","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T11:09:02Z","timestamp":1657364942000},"page":"109189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Maresin 2 is an analgesic specialized pro-resolution lipid mediator in mice by inhibiting neutrophil and monocyte recruitment, nociceptor neuron TRPV1 and TRPA1 activation, and CGRP release"],"prefix":"10.1016","volume":"216","author":[{"given":"Victor","family":"Fattori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago H.","family":"Zaninelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila R.","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Brasil-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio M.","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joice M.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana G.","family":"Chichorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubia","family":"Casagrande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-9283","authenticated-orcid":false,"suffix":"Jr.","given":"Waldiceu A.","family":"Verri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109189_bib1","doi-asserted-by":"crossref","first-page":"16526","DOI":"10.1073\/pnas.1407123111","article-title":"Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective","volume":"111","author":"Abdulnour","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109189_bib2","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1097\/j.pain.0000000000001908","article-title":"Imbalance of proresolving lipid mediators in persistent allodynia dissociated from signs of clinical arthritis","volume":"161","author":"Allen","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2022.109189_bib3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbalip.2010.08.002","article-title":"Specialized pro-resolving lipid mediators in the inflammatory response: an update","volume":"1801","author":"Bannenberg","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2022.109189_bib4","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: formation and actions of resolvins and protectins","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-019-0147-2","article-title":"Pain and immunity: implications for host defence","volume":"19","author":"Baral","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm.4501","article-title":"Nociceptor sensory neurons suppress neutrophil and \u03b3\u03b4 T cell responses in bacterial lung infections and lethal pneumonia","volume":"24","author":"Baral","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2022.109189_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41467-017-02448-6","article-title":"Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314","volume":"9","author":"Blake","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2022.109189_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ceca.2018.04.004","article-title":"Differential effects of lipopolysaccharide on mouse sensory TRP channels","volume":"73","author":"Boonen","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuropharm.2022.109189_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.1989.tb11926.x","article-title":"Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin","volume":"97","author":"Brain","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/srep35508","article-title":"Lipopolysaccharide-induced hemolysis: evidence for direct membrane interactions","volume":"6","author":"Brauckmann","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109189_bib11","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1182\/blood-2007-12-129767","article-title":"Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP","volume":"112","author":"Bystrom","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2022.109189_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090013","article-title":"Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4\/MyD88-dependent cytokine cascade in the mice paw","volume":"9","author":"Calil","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.109189_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.neuropharm.2022.109189_bib14","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1172\/JCI129448","article-title":"Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions","volume":"129","author":"Chiang","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2022.109189_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem."},{"key":"10.1016\/j.neuropharm.2022.109189_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature12479","article-title":"Bacteria activate sensory neurons that modulate pain and inflammation","volume":"501","author":"Chiu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109189_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/mi.2017.36","article-title":"Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection","volume":"11","author":"Codagnone","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib18","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1476-5381.2010.00950.x","article-title":"Lipoxin A(4) attenuates zymosan-induced arthritis by modulating endothelin-1 and its effects","volume":"161","author":"Conte","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1189\/jlb.0907654","article-title":"Crucial role of neutrophils in the development of mechanical inflammatory hypernociception","volume":"83","author":"Cunha","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1590\/S0100-879X2004000300018","article-title":"An electronic pressure-meter nociception paw test for mice","volume":"37","author":"Cunha","year":"2004","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.neuropharm.2022.109189_bib21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/bph.14336","article-title":"Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology","volume":"176","author":"Dalli","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib22","article-title":"Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages","volume":"9","author":"Deng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.109189_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phrs.2016.12.039","article-title":"Vinpocetine reduces diclofenac-induced acute kidney injury through inhibition of oxidative stress, apoptosis, cytokine production, and NF-kappaB activation in mice","volume":"120","author":"Fattori","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2022.109189_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.imlet.2020.11.009","article-title":"Neuroimmune communication in infection and pain: friends or foes?","volume":"229","author":"Fattori","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.neuropharm.2022.109189_bib25","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/bph.14647","article-title":"The specialised pro-resolving lipid mediator maresin 1 reduces inflammatory pain with a long-lasting analgesic effect","volume":"176","author":"Fattori","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib26","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/acs.jnatprod.9b00887","article-title":"Diosmin treats lipopolysaccharide-induced inflammatory pain and peritonitis by blocking NF-kappaB activation in mice","volume":"83","author":"Fattori","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.neuropharm.2022.109189_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104549","article-title":"Specialized pro-resolving lipid mediators: a new class of non-immunosuppressive and non-opioid analgesic drugs","volume":"151","author":"Fattori","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2022.109189_bib28","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2147\/JPR.S160779","article-title":"Pro-resolving mediator maresin 1 ameliorates pain hypersensitivity in a rat spinal nerve ligation model of neuropathic pain","volume":"11","author":"Gao","year":"2018","journal-title":"J. Pain Res."},{"key":"10.1016\/j.neuropharm.2022.109189_bib29","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbalip.2012.07.011","article-title":"Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS\/MS","volume":"1821","author":"Giera","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2022.109189_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2007.01.020","article-title":"A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain","volume":"129","author":"Goldberg","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2022.109189_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pbb.2006.05.008","article-title":"Hypernociception elicited by tibio-tarsal joint flexion in mice: a novel experimental arthritis model for pharmacological screening","volume":"84","author":"Guerrero","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109189_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/gast.2000.9561","article-title":"Nonsteroidal anti-inflammatory drug gastropathy","volume":"119","author":"Hawkey","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2022.109189_bib33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/jnr.1249","article-title":"PKC and PKA, but not PKG mediate LPS-induced CGRP release and [Ca(2+)](i) elevation in DRG neurons of neonatal rats","volume":"66","author":"Hou","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2022.109189_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107581","article-title":"Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential","volume":"212","author":"Jiang","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2022.109189_bib35","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib36","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1111\/bph.15178","article-title":"ARRIVE 2.0 and the British journal of pharmacology: updated guidance for 2020","volume":"177","author":"Lilley","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib37","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/ALN.0000000000001010","article-title":"Resolvin D1 inhibits mechanical hypersensitivity in sciatica by modulating the expression of nuclear factor-kappaB, phospho-extracellular signal-regulated kinase, and pro- and antiinflammatory cytokines in the spinal cord and dorsal root ganglion","volume":"124","author":"Liu","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2022.109189_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.toxicon.2014.12.007","article-title":"Analgesic effects of botulinum neurotoxin type A in a model of allyl isothiocyanate- and capsaicin-induced pain in mice","volume":"94","author":"Luvisetto","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2022.109189_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12974-016-0540-8","article-title":"Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection","volume":"13","author":"Martini","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2022.109189_bib40","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1038\/ncomms4125","article-title":"TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins","volume":"5","author":"Meseguer","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2022.109189_bib41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/2040622312454157","article-title":"Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity","volume":"3","author":"Meszaros","year":"2012","journal-title":"Ther. Adv. Chronic. Dis."},{"key":"10.1016\/j.neuropharm.2022.109189_bib42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/jpet.109.164806","article-title":"Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase","volume":"334","author":"Naidu","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109189_bib43","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1182\/blood-2014-03-562710","article-title":"Resolution of acute inflammation bridges the gap between innate and adaptive immunity","volume":"124","author":"Newson","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2022.109189_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-0040-1705959","article-title":"Synthesis of optically active maresin 2 and maresin 2n-3 DPA","volume":"32","author":"Ogawa","year":"2021","journal-title":"Synlett"},{"key":"10.1016\/j.neuropharm.2022.109189_bib45","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.4049\/jimmunol.1103652","article-title":"Resolvin E2 formation and impact in inflammation resolution","volume":"188","author":"Oh","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib46","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1086\/315093","article-title":"Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock","volume":"180","author":"Opal","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.neuropharm.2022.109189_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145019","article-title":"Resolvin D1 and D2 inhibit transient receptor potential vanilloid 1 and ankyrin 1 ion channel activation on sensory neurons via lipid raft modification","volume":"21","author":"Payrits","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109189_bib48","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.neuropharm.2016.02.019","article-title":"Naringenin reduces inflammatory pain in mice","volume":"105","author":"Pinho-Ribeiro","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109189_bib49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fimmu.2012.00298","article-title":"Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation","volume":"3","author":"Recchiuti","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib50","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.tetlet.2014.11.082","article-title":"First total synthesis of the macrophage derived anti-inflammatory and pro-resolving lipid mediator Maresin 2","volume":"56","author":"Rodriguez","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.neuropharm.2022.109189_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cbi.2015.05.007","article-title":"Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-kappaB","volume":"237","author":"Ruiz-Miyazawa","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuropharm.2022.109189_bib52","doi-asserted-by":"crossref","first-page":"12468","DOI":"10.1073\/pnas.1511003112","article-title":"Imaging robust microglial activation after lipopolysaccharide administration in humans with PET","volume":"112","author":"Sandiego","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109189_bib53","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.201601222R","article-title":"Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms","volume":"31","author":"Serhan","year":"2017","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2022.109189_bib54","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1096\/fj.11-201442","article-title":"Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain","volume":"26","author":"Serhan","year":"2012","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2022.109189_bib55","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib56","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1526-4637.2010.00983.x","article-title":"Causes and consequences of inadequate management of acute pain","volume":"11","author":"Sinatra","year":"2010","journal-title":"Pain Med."},{"key":"10.1016\/j.neuropharm.2022.109189_bib57","doi-asserted-by":"crossref","first-page":"15450","DOI":"10.1523\/JNEUROSCI.3859-11.2011","article-title":"Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice","volume":"31","author":"Sorge","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109189_bib58","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1182\/blood-2011-04-345330","article-title":"Transcriptomic analyses of murine resolution-phase macrophages","volume":"118","author":"Stables","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2022.109189_bib59","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJM198908033210503","article-title":"The cardiovascular response of normal humans to the administration of endotoxin","volume":"321","author":"Suffredini","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109189_bib60","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199305203282005","article-title":"Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin","volume":"328","author":"Taveira da Silva","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109189_bib61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/clc.22502","article-title":"Nonsteroidal anti-inflammatory drugs and risk of incident heart failure: a systematic review and meta-analysis of observational studies","volume":"39","author":"Ungprasert","year":"2016","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib62","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2006.04.001","article-title":"Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?","volume":"112","author":"Verri","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2022.109189_bib63","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3389\/fnins.2020.00831","article-title":"Maresin 1 attenuates radicular pain through the inhibition of NLRP3 inflammasome-induced pyroptosis via NF-kappaB signaling","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109189_bib64","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/ACO.0b013e32830eb69d","article-title":"Chemokines as pain mediators and modulators","volume":"21","author":"White","year":"2008","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbi.2016.03.026","article-title":"Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: the role of TLR4 in the evolution of a persistent pain state","volume":"56","author":"Woller","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2022.109189_bib66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11481-012-9394-8","article-title":"Resolvin E1 inhibits neuropathic pain and spinal cord microglial activation following peripheral nerve injury","volume":"8","author":"Xu","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib67","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nm.2123","article-title":"Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions","volume":"16","author":"Xu","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2022.109189_bib68","first-page":"1","article-title":"RvD1 disrupts nociceptor neuron and macrophage activation, and neuroimmune communication reducing pain and inflammation in gouty arthritis in mice","author":"Zaninelli","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.729134","article-title":"Harnessing inflammation resolution in arthritis: current understanding of specialized pro-resolving lipid mediators' contribution to arthritis physiopathology and future perspectives","volume":"12","author":"Zaninelli","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuropharm.2022.109189_bib70","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fphar.2018.00412","article-title":"Distinct analgesic actions of DHA and DHA-derived specialized pro-resolving mediators on post-operative pain after bone fracture in mice","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822002489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822002489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:19:37Z","timestamp":1758439177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822002489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":70,"alternative-id":["S0028390822002489"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109189","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maresin 2 is an analgesic specialized pro-resolution lipid mediator in mice by inhibiting neutrophil and monocyte recruitment, nociceptor neuron TRPV1 and TRPA1 activation, and CGRP release","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109189"}}